AI assistant
ANGIODYNAMICS INC — Director's Dealing 2020
Jul 21, 2020
32939_dirs_2020-07-21_927aa1fe-9f53-41c3-8525-d16dd6d4b52b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-07-17
Reporting Person: Campbell Chad Thomas (SVP/GM, Vascular Access)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-17 | Common Stock | F | 262 | $9.46 | Disposed | 24566 | Direct |
| 2020-07-18 | Common Stock | F | 224 | $9.21 | Disposed | 24342 | Direct |
| 2020-07-18 | Common Stock | F | 76 | $9.21 | Disposed | 24266 | Direct |
Footnotes
F1: The exempt disposition of 262 shares of common stock of AngioDynamics, Inc. ("Common Stock") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019.
F2: The exempt disposition of 224 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.
F3: The exempt disposition of 76 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018.